FABP5 and breast cancer: The fact that TNBC cell lines, MDA-MB-231 and MDA-MB-468, express high levels of FABP5 and are resistant to retinoid therapy suggests that by suppressing the expression level of FABP5, these subtypes of breast cancer cells can overcome RA resistance.